Related Experiment Videos
An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccines
L M Carruth1, T F Greten, C E Murray
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. lcarruth@welchlink.welch.jhu.edu
AIDS Research and Human Retroviruses
|August 13, 1999
Summary
This study investigated why some volunteers didn't develop HIV-1 specific T-cell responses after vaccination. Results suggest non-responsiveness wasn't due to typical immune system defects, indicating other factors may be involved in vaccine efficacy.
Area of Science:
- Immunology
- Vaccinology
- Virology
Background:
- Effective HIV-1 vaccines require robust immune responses, including cytotoxic T lymphocytes (CTLs) and neutralizing antibodies.
- Recombinant canarypox (CP)-based vectors (ALVAC) expressing HIV-1 genes are a promising vaccine strategy.
- Phase I trials showed significant CTL detection rates (60-70%) in HIV-1-seronegative volunteers receiving ALVAC-HIV.
Purpose of the Study:
- To evaluate factors associated with CTL responsiveness in volunteers vaccinated with ALVAC-HIV.
- To characterize CTL nonresponders and identify potential reasons for lack of response.
Main Methods:
- Analysis of CTL responses in a subset of ALVAC-HIV vaccinated volunteers.
- In-depth characterization of nonresponders, including antigen processing/presentation assays.
- Parallel assays for CMV-specific CTLs to rule out generalized defects.
- Flow cytometry to detect HIV-1 Gag epitope-specific T lymphocytes.
Main Results:
- Only one of seven examined volunteers showed detectable CTL responses (CD4+ and CD8+).
- This response waned by 1 year post-vaccination.
- Nonresponsiveness was not linked to antigen processing/presentation defects or generalized CTL deficits.
- HIV-1-specific memory CTLs were undetectable in nonresponders, unlike HIV-1-seropositive donors.
Conclusions:
- The lack of detectable HIV-1 CTLs in these volunteers was not attributable to classical MHC-linked nonresponsiveness.
- Further research is needed to understand the mechanisms underlying vaccine-induced CTL nonresponsiveness.